Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer (Q37702328)
Jump to navigation
Jump to search
scientific article published on 24 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer |
scientific article published on 24 March 2014 |
Statements
1 reference
Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer (English)
1 reference
1 reference
Justin M Balko
1 reference
Eric Winer
1 reference
Steven J Isakoff
1 reference
Ingrid A Mayer
1 reference
Vandana G Abramson
1 reference
Andres Forero
1 reference
MarÃa Gabriela Kuba
1 reference
Melinda E Sanders
1 reference
Annick D Van den Abbeele
1 reference
Carlos L Arteaga
1 reference
1 reference
Identifiers
1 reference